New England Healthcare Executive Network Meeting
Monday, March 7, 2016 from 7:30 AM to 10:00 AM
Financing Trends for Life Sciences and Healthcare Innovation
A Comprehensive Perspective of Today’s Financial Markets for Life Science Companies
Special Location: FOLEY HOAG LLP, Seaport West, 155 Seaport Boulevard, Boston. For Driving and Parking Information, Click Here.
ATTENTION: ONLINE REGISTRATION WILL END AT NOON ON THURSDAY, MARCH 3rd. ONSITE REGISTRATION WILL NOT BE PERMITTED FOR THIS EVENT. ALL REGISTERED ATTENDEES MUST PRESENT A PHOTO ID. SEATING IS LIMITED.
Join us for a panel discussion of the past, present and future trends in life science financial markets. Healthcare companies have livened the public stock markets with significant gains over the last five years including a 150% increase in the NYSE ARCA Biotech Index (BTK) as of January 22nd and over 160 IPOs and significant M&A activity. However, the BTK has dropped over 25% in the last six months creating new uncertainties driven by drug pricing, data, expectations, execution and many other factors. Our panel includes experts from across the industry that are on the front lines. Let’s hear what they have so say about the future moving forward.
Program Moderator: Douglas MacDougall, President, MacDougall Biomedical Communications
Noubar Afeyan, Ph.D., Senior Managing Partner and CEO, Flagship Partners, Boston
Adam Feuerstein, Senior Columnist, TheStreet
Peter Kolchinski, Ph.D., Managing Partner, RA Capital Management, LLC
Peter Riekes, Vice Chairman, Investment Banking Division, Stifel, Nicolaus & Company, Inc.
Send this to a friend